2-231206251-C-G
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_001352754.2(ARMC9):āc.13C>Gā(p.Leu5Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000496 in 1,613,800 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_001352754.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARMC9 | NM_001352754.2 | c.13C>G | p.Leu5Val | missense_variant | 2/25 | ENST00000611582.5 | NP_001339683.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARMC9 | ENST00000611582.5 | c.13C>G | p.Leu5Val | missense_variant | 2/25 | 5 | NM_001352754.2 | ENSP00000484804 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000335 AC: 51AN: 152150Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000716 AC: 18AN: 251308Hom.: 0 AF XY: 0.0000736 AC XY: 10AN XY: 135836
GnomAD4 exome AF: 0.0000198 AC: 29AN: 1461532Hom.: 0 Cov.: 30 AF XY: 0.0000248 AC XY: 18AN XY: 727104
GnomAD4 genome AF: 0.000335 AC: 51AN: 152268Hom.: 0 Cov.: 32 AF XY: 0.000282 AC XY: 21AN XY: 74454
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 10, 2022 | The c.13C>G (p.L5V) alteration is located in exon 2 (coding exon 1) of the ARMC9 gene. This alteration results from a C to G substitution at nucleotide position 13, causing the leucine (L) at amino acid position 5 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 01, 2022 | This sequence change replaces leucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 5 of the ARMC9 protein (p.Leu5Val). This variant is present in population databases (rs376958829, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with ARMC9-related conditions. ClinVar contains an entry for this variant (Variation ID: 967189). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at